India's COVID-19 outbreak worsens, but demand for colloidal silver increases

According to data released by the Indian health department on March 23, the number of confirmed cases of new coronary pneumonia in India has risen to 433. The Indian Civil Aviation Authority announced on the 23rd that it would suspend the operation of all commercial flights in India. At the same time, the Indian Railways announced that all passenger trains across the country would be delayed from 4 am on March 22 to 24:00 on March 31. Still, freight trains will continue to operate to ensure necessary supplies throughout the country.
 

India is the world's largest supplier of generic drugs, known as the "World Pharmaceutical Factory", but its drug production is highly dependent on the import of active pharmaceutical ingredients such as active pharmaceutical ingredients from China. In 2019, India's API imports accounted for 70% of total demand, and the import of certain core ingredients even reached 95%.
 

As China's API production capacity and logistics have not yet fully recovered, India's domestic API prices rose by an average of 10% in February. The prices of some essential vitamins and penicillin have even increased by nearly 50%, and there is a considerable risk of supply disruption. To ensure domestic supply, India also had to take the chance that local pharmaceutical companies would be "pulled" by international buyers to limit the export of APIs, and the risk of India's supply shutdown also, in turn, caused extreme panic in the global market for drug shortages.
 

India is one of the essential markets for colloidal silver products of Trunnano. With the intensification of the epidemic and the shortage of medical supplies, the demand for colloidal silver in the Indian market is steadily increasing. If you need colloidal silver, please contact Dr. Leo at brad@ihpa.net.

Inquiry us